NEW APPROACHES IN THE TREATMENT OF CHRONIC VIRAL EPSTEIN-BARR INFECTION
- 作者: Rakityanskaya I.A.1, Ryabova T.S1,2, Todzhibaev U.A1, Kalashnikova A.A3
-
隶属关系:
- Saint Petersburg Municipal City Polyclinic No 112
- S.M. Kirov Military Medical Academy
- A.M. Nikiforov All-Russian Center for Emergency and Radiation Medicine
- 期: 卷 6, 编号 1 (2019)
- 页面: 19-26
- 栏目: Original study articles
- URL: https://journals.rcsi.science/2313-8726/article/view/35456
- DOI: https://doi.org/10.18821/2313-8726-2019-6-1-19-26
- ID: 35456
如何引用文章
全文:
详细
作者简介
Irina Rakityanskaya
Saint Petersburg Municipal City Polyclinic No 112
Email: tat-akyla@inbox.ru
MD, Ph.D., DSci., professor of the Outpatient Department of Allergology-Immunology and Clinical Transfusiology of the Saint Petersburg Municipal City Polyclinic No 112, St. Petersburg, 195427, Russian Federation St. Petersburg, 195427, Russian Federation
T. Ryabova
Saint Petersburg Municipal City Polyclinic No 112; S.M. Kirov Military Medical AcademySt. Petersburg, 195427, Russian Federation; St. Petersburg, 194044, Russian Federation
U. Todzhibaev
Saint Petersburg Municipal City Polyclinic No 112St. Petersburg, 195427, Russian Federation
A. Kalashnikova
A.M. Nikiforov All-Russian Center for Emergency and Radiation MedicineSt. Petersburg, 194044, Russian Federation
参考
- Straus S.E. The chronic mononucleosis syndrome. J. Infect. Dis. 1988;157: 405-12.
- Hellmann D., Cowan M.J., Ammann A.J., Wara D.W., Chudwin D., Chang R.S. Chronic active Epstein-Barr virus infections in two immunodeficient patients. J. Pediatr. 1983; 103: 585-8.
- Choen J.L. Epstein-Barr virus infection. N. Engl. J. Med. 2000; 343: 480-92.
- Thorley-Lawson D.A. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 2001; 1: 75-82. doi: 10.1038/35095584
- Laichalk L.L., Thorley-Lawson D.A. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 2005; 79: 1296-1307. doi: 10.1128/JVI.79.2.1296-1307.2005
- Kieff E., Rickinson A.B. Epstein-Barr virus and its replication. In: Knipe D.M., Howley P.M., eds. Fields Virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
- Laichalk L.L., Hochberg D., Babcock G.J, Freeman R.B., Thorley-Lawson D.A. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity. 2002;16:745-54.
- Amyes E., Hatton C., Montamat-Sicotte D., Gudgeon N., Rickinson A.B., McMichael A.J. et al. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J. Exp. Med. 2003; 198(6): 903-11.
- Marrão G., Habib M., Paiva A., Bicout D., Fallecker C., Franco S. et al. Epstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ response. BMC Cancer. 2014; 14: 665.
- Kimura H., Hoshino Y., Kanegane H., Tsuge I., Okamura T., Kawa K. et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001; 98: 280-6.
- Zhao X., Wu H., Lu H., Li G., Huang Q. Lamp: a database linking antimicrobial peptides. PLoS One. 2013; 8: e66557. doi: 10.1371/journal.pone.0066557.
- Conlon J.M., Sonnevend A. Antimicrobial peptides in frog skin secretions. Methods Mol. Biol. 2010; 618: 3-14.
- Bahar A.A., Ren D. Antimicrobial peptides. Pharmaceuticals (Basel). 2013; 6(12): 1543-75. doi: 10.3390/ph6121543.
- Altfeld M., Gale M.Jr. Innate immunity against HIV-1 infection. Nat. Immunol. 2015;16(6): 554-62. doi: 10.1038/ni.3157.
- Meije Y., Tonjes R.R., Fishman J.A. Retroviral restriction factors and infectious risk in xenotransplantation. Am. J. Transplant. 2010; 10(7): 1511-6. doi: 10.1111/j.1600-6143.2010.03146.x.
- Chernysh S., Kim S., Bekker G., Pleskach V.A., Filatova N.A., Anikin V.B. et al. Antiviral and antitumor peptides from insects. Proc. Natl. Acad. Sci. USA. 2002; 99(20): 12628-32. doi: [10.1073/pnas.192301899]
- Mabbott N.A., Brown K.L., Manson J., Bruce M.E. T-lymphocyte activation and the cellular form of the prion protein. Immunology. 1997; 92(2):161-5.
- Lee N., Bae S., Kim H., Kong J.M., Kim H.R., Cho B.J. et al. Inhibition of lytic reactivation of Kaposi’s sarcoma-associated herpesvirus by alloferon. Antivir. Ther. 2011; 16: 17-26.
- Bae S., Oh K., Kim H., Kim Y., Kim H.R., Hwang Y.I. et al. The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin/granzyme B secretion. Immunobiology. 2013; 218: 1026-33.
- Kim Y., Lee S.K., Bae S., Kim H., Park Y., Chu N.K. et al. The anti-inflammatory effect of alloferon on UVB-induced skin inflammation through the down-regulation of pro-inflammatory cytokines. Immunol. Lett. 2013;149: 110-8.
- Kuczer M., Dziubasik K., Midak-Siewirska A., Zahorska R., Łuczak M., Konopińska D. Studies of insect peptides alloferon, Any-GS and their analogues. Synthesis and antiherpes activity. J. Pept. Sci. 2010;16(4):186-9.
- Kuczer M., Majewska A., Zahorska R. New alloferon analogues: synthesis and antiviral properties. Chem. Biol. Drug Des. 2013; 81(2): 302-9. doi: 10.1111/cbdd.12020
- Kuczer M., Czarniewska E., Majewska A., Różanowska M., Rosiński G., Lisowski M. Novel analogs of alloferon: Synthesis, conformational studies, pro-apoptotic and antiviral activity. Bioorg. Chem. 2016; 66: 12-20. doi: 10.1016/j.bioorg.2016.03.002.
- Kragsbjerg P. Chronic active mononucleosis. Scand. J. Infect. Dis. 1997; 29 (5): 517-8.
- Gustafson E.A., Chillemi A.C., Sage D.R., Fingeroth J.D. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase. Antimicrob. Agents Chemother. 1998;42(11): 2923-31.
- Хахалин Л.Н., Абазова Ф.И. Ацикловир при лечении острых и рецидивирующих герпесвирусных инфекций. Клин. фармакол., терапия. 1995; 4: 78-81
- Cohen J.I. Optimal treatment for chronic active Epstein-Barr virus disease. Pediatr. Transplant. 2009; 13(4): 393-6. doi: 10.1111/j.1399-3046.2008.01095.x
- De Paor M., O’Brien K., Fahey T., Smith S.M. Antiviral agents for infectious mononucleosis (glandular fever). Cochrane Database Syst. Rev. 2016; 8(12): CD011487. doi: 10.1002/14651858.
- Казмирчук В.Е., Мальцев Д.В. Клиника, диагностика и лечение герпесвирусных инфекций человека. К.: Феникс; 2009
- Martinez J.P., Sasse F., Brönstrup M., Diez J., Meyerhans A. Antiviral drug discovery: broad-spectrum drugs from nature. Nat. Prod. Rep. 2015; 32(1): 29-48. doi: 10.1039/C4NP00085D
- Коновалова Н.В., Храменко Н.И., Величко Л.Н., Юрченко Л.А. Роль уровня интерферонов α и γ в крови больных увеитами вирусной этиологии под влиянием лечения препаратом аллокин-альфа. Точка зрения. Восток - Запад. 2018; (4): 26-9. DOI: https://doi.org/10.25276/2410-1257-2018-4-26-29
- Серебряков М.Ю., Тищенко М.С., Воронов А.В., Салимов А.Г., Сметанина С.Е., Платонова Т.К. и др. Новые подходы к лечению больных ВЭБ-инфекцией. В кн.: Сборник научных трудов по препарату Аллокин-альфа. М.; 2016: 181-4.
补充文件
